Lilly revenue rises 7.2 pct on higher demand for new drugs
January 31, 2017 at 06:33 AM EST
Jan 31 (Reuters) - Eli Lilly and Co reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments.
